TargetNet: a web service for predicting potential drug–target interaction profiling via multi-target SAR models

Drug–target interactions (DTIs) are central to current drug discovery processes and public health fields. Analyzing the DTI profiling of the drugs helps to infer drug indications, adverse drug reactions, drug–drug interactions, and drug mode of actions. Therefore, it is of high importance to reliably and fast predict DTI profiling of the drugs on a genome-scale level. Here, we develop the TargetNet server, which can make real-time DTI predictions based only on molecular structures, following the spirit of multi-target SAR methodology. Naïve Bayes models together with various molecular fingerprints were employed to construct prediction models. Ensemble learning from these fingerprints was also provided to improve the prediction ability. When the user submits a molecule, the server will predict the activity of the user’s molecule across 623 human proteins by the established high quality SAR model, thus generating a DTI profiling that can be used as a feature vector of chemicals for wide applications. The 623 SAR models related to 623 human proteins were strictly evaluated and validated by several model validation strategies, resulting in the AUC scores of 75–100 %. We applied the generated DTI profiling to successfully predict potential targets, toxicity classification, drug–drug interactions, and drug mode of action, which sufficiently demonstrated the wide application value of the potential DTI profiling. The TargetNet webserver is designed based on the Django framework in Python, and is freely accessible at http://targetnet.scbdd.com.

[1]  K. Chou,et al.  iGPCR-Drug: A Web Server for Predicting Interaction between GPCRs and Drugs in Cellular Networking , 2013, PloS one.

[2]  Xiaobo Zhou,et al.  Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces , 2010, BMC Systems Biology.

[3]  Hua Yu,et al.  A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data , 2012, PloS one.

[4]  Lin He,et al.  DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome , 2011, Nucleic Acids Res..

[5]  Diego di Bernardo,et al.  Identifying Network of Drug Mode of Action by Gene Expression Profiling , 2009, J. Comput. Biol..

[6]  R. Sharan,et al.  PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.

[7]  K. Chou,et al.  Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features , 2010, PloS one.

[8]  Dong-Sheng Cao,et al.  PyDPI: Freely Available Python Package for Chemoinformatics, Bioinformatics, and Chemogenomics Studies , 2013, J. Chem. Inf. Model..

[9]  Paul Watson,et al.  Naïve Bayes Classification Using 2D Pharmacophore Feature Triplet Vectors , 2008, J. Chem. Inf. Model..

[10]  Yoshihiro Yamanishi,et al.  Supervised prediction of drug–target interactions using bipartite local models , 2009, Bioinform..

[11]  Qingsong Xu,et al.  Computer‐aided prediction of toxicity with substructure pattern and random forest , 2012 .

[12]  R. Tagliaferri,et al.  Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.

[13]  Minho Lee,et al.  Large-scale reverse docking profiles and their applications , 2012, BMC Bioinformatics.

[14]  L. Wienkers,et al.  Predicting in vivo drug interactions from in vitro drug discovery data , 2005, Nature Reviews Drug Discovery.

[15]  Jennifer Venhorst,et al.  Target-drug interactions: first principles and their application to drug discovery. , 2012, Drug discovery today.

[16]  E. Jacoby,et al.  Chemogenomics: an emerging strategy for rapid target and drug discovery , 2004, Nature Reviews Genetics.

[17]  Yoshihiro Yamanishi,et al.  Relating drug–protein interaction network with drug side effects , 2012, Bioinform..

[18]  Hua Xu,et al.  Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs , 2012, J. Am. Medical Informatics Assoc..

[19]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[20]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[21]  E. Marcotte,et al.  A flaw in the typical evaluation scheme for pair-input computational predictions , 2012, Nature Methods.

[22]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[23]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[24]  Sona Warrier,et al.  Reverse docking: a powerful tool for drug repositioning and drug rescue. , 2014, Future medicinal chemistry.

[25]  T. Klabunde.  Chemogenomic approaches to drug discovery: similar receptors bind similar ligands , 2007, British journal of pharmacology.

[26]  Yadi Zhou,et al.  Prediction of Chemical-Protein Interactions Network with Weighted Network-Based Inference Method , 2012, PloS one.

[27]  Chuang Liu,et al.  Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..

[28]  Yadi Zhou,et al.  Prediction of chemical-protein interactions: multitarget-QSAR versus computational chemogenomic methods. , 2012, Molecular bioSystems.

[29]  Tapio Pahikkala,et al.  Toward more realistic drug^target interaction predictions , 2014 .

[30]  Ping Zhang,et al.  DDI-CPI, a server that predicts drug–drug interactions through implementing the chemical–protein interactome , 2014, Nucleic Acids Res..

[31]  Ghent,et al.  CPT: Pharmacometrics & Systems Pharmacology , 2013, CPT: pharmacometrics & systems pharmacology.

[32]  Shiew-Mei Huang,et al.  Predicting Drug–Drug Interactions: An FDA Perspective , 2009, The AAPS Journal.

[33]  D. Scott,et al.  Fragment-based approaches in drug discovery and chemical biology. , 2012, Biochemistry.

[34]  Chee Keong Kwoh,et al.  Drug-target interaction prediction by learning from local information and neighbors , 2013, Bioinform..

[35]  Dong-Sheng Cao,et al.  Large-scale prediction of drug-target interactions using protein sequences and drug topological structures. , 2012, Analytica chimica acta.

[36]  Xiaomin Luo,et al.  TarFisDock: a web server for identifying drug targets with docking approach , 2006, Nucleic Acids Res..

[37]  Xing Chen,et al.  Drug-target interaction prediction by random walk on the heterogeneous network. , 2012, Molecular bioSystems.

[38]  Elena Marchiori,et al.  Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..

[39]  Péter Csermely,et al.  The efficiency of multi-target drugs: the network approach might help drug design. , 2004, Trends in pharmacological sciences.

[40]  P. Bork,et al.  Drug Target Identification Using Side-Effect Similarity , 2008, Science.

[41]  Andreas Bender,et al.  Molecular Similarity Searching Using Atom Environments, Information-Based Feature Selection, and a Naïve Bayesian Classifier , 2004, J. Chem. Inf. Model..

[42]  Jean-Philippe Vert,et al.  Protein-ligand interaction prediction: an improved chemogenomics approach , 2008, Bioinform..

[43]  Yasubumi Sakakibara,et al.  Statistical prediction of protein-chemical interactions based on chemical structure and mass spectrometry data , 2007, Bioinform..

[44]  Dong-Sheng Cao,et al.  ChemoPy: freely available python package for computational biology and chemoinformatics , 2013, Bioinform..

[45]  Yoshihiro Yamanishi,et al.  DINIES: drug–target interaction network inference engine based on supervised analysis , 2014, Nucleic Acids Res..

[46]  R. Altman,et al.  Data-Driven Prediction of Drug Effects and Interactions , 2012, Science Translational Medicine.

[47]  Gong-Hua Li,et al.  CDRUG: a web server for predicting anticancer activity of chemical compounds , 2012, Bioinform..

[48]  Dong-Sheng Cao,et al.  Genome-Scale Screening of Drug-Target Associations Relevant to Ki Using a Chemogenomics Approach , 2013, PloS one.

[49]  Yoshihiro Yamanishi,et al.  Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.

[50]  Youyong Li,et al.  ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage. , 2012, Molecular pharmaceutics.